Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Implants / Devices
    • Omron Healthcare India...

    Omron Healthcare India eyes 45 percent revenue growth in FY 18-19

    Written by Ruby Khatun Khatun Published On 2018-01-24T10:36:41+05:30  |  Updated On 24 Jan 2018 10:36 AM IST
    Omron Healthcare India eyes 45 percent revenue growth in FY 18-19

    New Delhi: Japanese medical devices maker Omron Healthcare is targeting around 45 percent rise in revenues at Rs 189 crore in the next fiscal year aided by expansion in tier-I and tier-II cities.


    The company also plans the expansion of sales network and use of e-commerce for promoting its products.


    "We are looking at revenues of Rs 189 crore in the fiscal year 2018-19. We are expecting Rs 130 crore in revenues in the current financial year," Omron Healthcare India Pvt Ltd Managing Director Kazunori Tokura told.


    "One of the important focus areas for us is geographical expansion across India and we are targeting tier I and tier II cities for this," Tokura said.


    The company also plans to expand its retail presence across the country, he added.


    "Going forward the company will also enhance interaction with consumers. We will be using both off-line and online mediums for this. We will use e-commerce to grow the business, we will also use it to educate the consumers," he added.


    Highlighting the importance of India, Tokura said India is a very important for the company.


    When asked if the company had any plans to set up a manufacturing unit in India, he said: "Not in the near future. In the long term, once we achieve a significant volume for our products then we may consider it."


    Omron Healthcare product line in the country includes products such as blood pressure monitors, blood glucose monitors, thermometers, nebulizers, respiratory devices and body composition monitors.

    45 percentblood glucose monitorsblood pressure monitorsExpansioneyesKazunori TokuraMedical DevicesnebulizersOmron HealthcareOmron Healthcare Indiarespiratory devicesrevenue growththermometers
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok